1.
Md Shams Tabrez1, Ravi Kumar2, Veena Kumari3*. Renal and Glycemic Outcomes with Linagliptin versus Vildagliptin as Add-On Therapy in Uncontrolled Type 2 Diabetes Mellitus: A Prospective Observational Study. IJMSCRR [Internet]. 2026 Aug. 16 [cited 2026 Oct. 19];9(04):Page: 897-910. Available from: https://ijmscrr.in/index.php/ijmscrr/article/view/1474